Overview
Don Park is a Hematologist Oncology specialist and a Hematologist in Allentown, Pennsylvania. Dr. Park is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1240 S Cedar Crest Blvd, 305 Lvpg Hematology Oncolo, Allentown, PA 18103
Abramson Cancer Center Radnor
David Henry is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Henry is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Iron Deficiency Anemia, Bone Marrow Aspiration, and Endoscopy. Dr. Henry is currently accepting new patients.
Penn Blood Disorders Center
Adam Cuker is a Hematologist in Philadelphia, Pennsylvania. Dr. Cuker is rated as an Elite provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Splenectomy, and Knee Replacement. Dr. Cuker is currently accepting new patients.
Lehigh Valley Physician Group
Bradley Lash is a Hematologist Oncology specialist and a Hematologist in Allentown, Pennsylvania. Dr. Lash is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Non-Hodgkin LymphomaDr. Park isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Acute Mountain SicknessDr. Park isAdvanced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Park isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Park isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Park isAdvanced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Park isAdvanced. Learn about Aplastic Anemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Park isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Park isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic LeukemiaDr. Park isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Soft Tissue SarcomaDr. Park isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer